Translational regulation of the mRNA encoding the ubiquitin peptidase USP1 involved in the DNA damage response as a determinant of Cisplatin resistance

References

• Hu L, Wu C, Zhao X, Heist R, Su L, Zhao Y, Han B, Cao S, Chu M, Dai J, et al. Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy. Clin Cancer Res 2012; 18:5507-14; PMID:22872573; http://dx.doi.org/10.1158/1078-0432.CCR-12-1202
   PubMed Web of Science ®Google Scholar
• Lin M, Stewart DJ, Spitz MR, Hildebrandt MA, Lu C, Lin J, Gu J, Huang M, Lippman SM, Wu X. Genetic variations in the transforming growth factor-β pathway as predictors of survival in advanced non-small cell lung cancer. Carcinogenesis 2011; 32:1050-6; PMID:21515830; http://dx.doi.org/10.1093/carcin/bgr067
   PubMed Web of Science ®Google Scholar
• Li Y, Sun Z, Cunningham JM, Aubry MC, Wampfler JA, Croghan GA, Johnson C, Wu D, Aakre JA, Molina J, et al. Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy. Clin Cancer Res 2011; 17:3830-40; PMID:21636554; http://dx.doi.org/10.1158/1078-0432.CCR-10-2877
   PubMed Web of Science ®Google Scholar
• Wagner KW, Ye Y, Lin J, Vaporciyan AA, Roth JA, Wu X. Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients. Clin Cancer Res 2012; 18:585-92; PMID:22252258; http://dx.doi.org/10.1158/1078-0432.CCR-11-2087
   PubMed Web of Science ®Google Scholar
• Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, Parkinson C, Chin SF, Kingsbury Z, Wong AS, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 2013; 497:108-12; PMID:23563269; http://dx.doi.org/10.1038/nature12065
   PubMed Web of Science ®Google Scholar
• Lai TC, Chow KC, Fang HY, Cho HC, Chen CY, Lin TY, Chiang IP, Ho SP. Expression of xeroderma pigmentosum complementation group C protein predicts cisplatin resistance in lung adenocarcinoma patients. Oncology Reports 2011; 25:1243-51; PMID:21327329
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhong M, Liu W, Li J, Huang J, Zheng L. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP). Exp Lung Res 2011; 37:427-34; PMID:21787234; http://dx.doi.org/10.3109/01902148.2011.584263
   PubMed Web of Science ®Google Scholar
• Zhou L, Qiu T, Xu J, Wang T, Wang J, Zhou X, Huang Z, Zhu W, Shu Y, Liu P. miR-135a/b modulate cisplatin resistance of human lung cancer cell line by targeting MCL1. Pathol Oncol Res 2013; 19:677-83; PMID:23640248; http://dx.doi.org/10.1007/s12253-013-9630-4
   PubMed Web of Science ®Google Scholar
• Yang Y, Li H, Hou S, Hu B, Liu J, Wang J. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. PloS One 2013; 8:e65309; PMID:23741487; http://dx.doi.org/10.1371/journal.pone.0065309
   PubMed Web of Science ®Google Scholar
• Jacquemont C, Simon JA, D'Andrea AD, Taniguchi T. Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin. Mol Cancer 2012; 11:26; PMID:22537224; http://dx.doi.org/10.1186/1476-4598-11-26
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Goubar A, Olaussen KA, Vitale I, Senovilla L, Michels J, Robin A, Dorvault N, Besse B, Validire P, et al. Prognostic value of LIPC in non-small cell lung carcinoma. Cell Cycle (Georgetown, Tex) 2013; 12:647-54; PMID:23343765; http://dx.doi.org/10.4161/cc.23517
   PubMed Web of Science ®Google Scholar
• Olaussen KA, Dunant A, Fouret P, Brambilla E, Andre F, Haddad V, Taranchon E, Filipits M, Pirker R, Popper HH, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Eng J Med 2006; 355:983-91; PMID:16957145; http://dx.doi.org/10.1056/NEJMoa060570
   PubMed Web of Science ®Google Scholar
• Mazan-Mamczarz K, Kawai T, Martindale JL, Gorospe M. En masse analysis of nascent translation using microarrays. Bio Techn 2005; 39:61-2: 4: 6-7
   Google Scholar
• Powley IR, Kondrashov A, Young LA, Dobbyn HC, Hill K, Cannell IG, Stoneley M, Kong YW, Cotes JA, Smith GC, et al. Translational reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective recruitment to the polysomes of mRNAs encoding DNA repair enzymes. Genes Dev 2009; 23:1207-20; PMID:19451221; http://dx.doi.org/10.1101/gad.516509
   PubMed Web of Science ®Google Scholar
• Cammas A, Pileur F, Bonnal S, Lewis SM, Leveque N, Holcik M, Vagner S. Cytoplasmic relocalization of heterogeneous nuclear ribonucleoprotein A1 controls translation initiation of specific mRNAs. Mol Biol Cell 2007; 18:5048-59; PMID:17898077; http://dx.doi.org/10.1091/mbc.E07-06-0603
   PubMed Web of Science ®Google Scholar
• Dutertre M, Lambert S, Carreira A, Amor-Gueret M, Vagner S. DNA damage: RNA-binding proteins protect from near and far. Trends Biochem Sci 2014; 39:141-9; PMID:24534650; http://dx.doi.org/10.1016/j.tibs.2014.01.003
   PubMed Web of Science ®Google Scholar
• Zeng HZ, Qu YQ, Zhang WJ, Xiu B, Deng AM, Liang AB. Proteomic analysis identified DJ-1 as a cisplatin resistant marker in non-small cell lung cancer. Int J Mol Sci 2011; 12:3489-99; PMID:21747690; http://dx.doi.org/10.3390/ijms12063489
   PubMed Web of Science ®Google Scholar
• Huang W, Ding X, Li B, Fan M, Zhou T, Sun H, Yi Y, Zhang J. Serum biomarkers analyzed by LC-MS/MS as predictors for short outcome of non-small cell lung cancer patients treated with chemoradiotherapy. Neoplasma 2013; 60:11-8; PMID:23067211; http://dx.doi.org/10.4149/neo_2013_002
   PubMed Web of Science ®Google Scholar
• Kumaraswamy S, Chinnaiyan P, Shankavaram UT, Lu X, Camphausen K, Tofilon PJ. Radiation-induced gene translation profiles reveal tumor type and cancer-specific components. Cancer Res 2008; 68:3819-26; PMID:18483266; http://dx.doi.org/10.1158/0008-5472.CAN-08-0016
   PubMed Web of Science ®Google Scholar
• Michels J, Vitale I, Galluzzi L, Adam J, Olaussen KA, Kepp O, Senovilla L, Talhaoui I, Guegan J, Enot DP, et al. Cisplatin resistance associated with PARP hyperactivation. Cancer Res 2013; 73:2271-80; PMID:23554447; http://dx.doi.org/10.1158/0008-5472.CAN-12-3000
   PubMed Web of Science ®Google Scholar
• Cohn MA, Kowal P, Yang K, Haas W, Huang TT, Gygi SP, D'Andrea AD. A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol Cell 2007; 28:786-97; PMID:18082604; http://dx.doi.org/10.1016/j.molcel.2007.09.031
   PubMed Web of Science ®Google Scholar
• Nijman SM, Huang TT, Dirac AM, Brummelkamp TR, Kerkhoven RM, D'Andrea AD, Bernards R. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell 2005; 17:331-9; PMID:15694335; http://dx.doi.org/10.1016/j.molcel.2005.01.008
   PubMed Web of Science ®Google Scholar
• Oestergaard VH, Langevin F, Kuiken HJ, Pace P, Niedzwiedz W, Simpson LJ, Ohzeki M, Takata M, Sale JE, Patel KJ. Deubiquitination of FANCD2 is required for DNA crosslink repair. Mol Cell 2007; 28:798-809; PMID:18082605; http://dx.doi.org/10.1016/j.molcel.2007.09.020
   PubMed Web of Science ®Google Scholar
• Kim JM, Parmar K, Huang M, Weinstock DM, Ruit CA, Kutok JL, D'Andrea AD. Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype. Dev Cell 2009; 16:314-20; PMID:19217432; http://dx.doi.org/10.1016/j.devcel.2009.01.001
   PubMed Web of Science ®Google Scholar
• Hussain S, Wilson JB, Medhurst AL, Hejna J, Witt E, Ananth S, Davies A, Masson JY, Moses R, West SC, et al. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum Mol Genetics 2004; 13:1241-8; PMID:15115758; http://dx.doi.org/10.1093/hmg/ddh135
   PubMed Web of Science ®Google Scholar
• Howlett NG, Taniguchi T, Durkin SG, D'Andrea AD, Glover TW. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genetics 2005; 14:693-701; PMID:15661754; http://dx.doi.org/10.1093/hmg/ddi065
   PubMed Web of Science ®Google Scholar
• Huang TT, Nijman SM, Mirchandani KD, Galardy PJ, Cohn MA, Haas W, Gygi SP, Ploegh HL, Bernards R, D'Andrea AD. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat Cell Biol 2006; 8:339-47; PMID:16531995
   PubMed Web of Science ®Google Scholar
• Chen J, Dexheimer TS, Ai Y, Liang Q, Villamil MA, Inglese J, Maloney DJ, Jadhav A, Simeonov A, Zhuang Z. Selective and cell-active inhibitors of the USP1/ UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells. Chem Biol 2011; 18:1390-400; PMID:22118673; http://dx.doi.org/10.1016/j.chembiol.2011.08.014
   PubMed Web of Science ®Google Scholar
• Liang Q, Dexheimer TS, Zhang P, Rosenthal AS, Villamil MA, You C, Zhang Q, Chen J, Ott CA, Sun H, et al. A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses. Nat Chem Biol 2014; 10:298-304; PMID:24531842; http://dx.doi.org/10.1038/nchembio.1455
   PubMed Web of Science ®Google Scholar
• Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, Grompe M, D'Andrea AD. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 2001; 7:249-62; PMID:11239454; http://dx.doi.org/10.1016/S1097-2765(01)00173-3
   PubMed Web of Science ®Google Scholar
• Rajendra E, Oestergaard VH, Langevin F, Wang M, Dornan GL, Patel KJ, Passmore LA. The genetic and biochemical basis of FANCD2 monoubiquitination. Mol Cell 2014; 54:858-69; PMID:24905007; http://dx.doi.org/10.1016/j.molcel.2014.05.001
   PubMed Web of Science ®Google Scholar
• de Winter JP, van der Weel L, de Groot J, Stone S, Waisfisz Q, Arwert F, Scheper RJ, Kruyt FA, Hoatlin ME, Joenje H. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genetics 2000; 9:2665-74; PMID:11063725; http://dx.doi.org/10.1093/hmg/9.18.2665
   PubMed Web of Science ®Google Scholar
• Liu Y, Luo X, Hu H, Wang R, Sun Y, Zeng R, Chen H. Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer. PloS One 2012; 7:e51748; PMID:23284758; http://dx.doi.org/10.1371/journal.pone.0051748
   PubMed Web of Science ®Google Scholar
• Zhiqiang Z, Qinghui Y, Yongqiang Z, Jian Z, Xin Z, Haiying M, Yuepeng G. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells. J Cancer Res Clin Oncol 2012; 138:1231-8; PMID:22426999; http://dx.doi.org/10.1007/s00432-012-1193-3
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43:e47; PMID:25605792; http://dx.doi.org/10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar